Donna E Hogge Selected Research

Donna E Hogge Research Topics

Disease

25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2002
6	Leukemia 03/2016 - 04/2006
6	Diphtheria 01/2010 - 11/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2015 - 10/2006
3	Disease Progression 08/2015 - 11/2004
3	Neoplasms (Cancer) 06/2015 - 04/2008
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018 - 06/2006
2	Lymphoma (Lymphomas) 06/2015 - 10/2005
2	Multiple Myeloma 01/2011 - 08/2007
2	Infertility (Sterility) 01/2010 - 01/2004
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2009 - 11/2005
2	Hodgkin Disease (Hodgkin's Disease) 11/2005 - 08/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2005 - 11/2004
2	Chromosome Aberrations (Chromosome Abnormalities) 10/2003 - 01/2002
1	Infections 05/2014
1	Cytopenia 05/2014
1	Hematologic Neoplasms (Hematological Malignancy) 04/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2012
1	Blast Crisis (Blast Phase) 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 12/2011
1	Pathologic Complete Response 07/2006
1	Second Primary Neoplasms (Neoplasms, Second) 11/2005
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2004
1	Hematologic Diseases (Blood Diseases) 06/2003

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 08/2010 - 03/2002
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2004
6	Diphtheria ToxinIBA 08/2010 - 03/2002
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 11/2004
5	Interleukin-3 (Interleukin 3)IBA 08/2010 - 03/2002
4	Imatinib Mesylate (Gleevec)FDA Link 07/2012 - 10/2006
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 07/2011
3	CPX-351IBA 01/2021 - 07/2011
3	Tyrosine Kinase InhibitorsIBA 08/2015 - 05/2010
2	Rituximab (Mabthera)FDA Link 01/2018 - 06/2015
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2015 - 09/2012
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2015 - 04/2008
2	Adenosine Triphosphate (ATP)IBA 07/2015 - 04/2008
2	Etoposide (VP 16)FDA LinkGeneric 06/2015 - 04/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015 - 04/2006
2	Protein Isoforms (Isoforms)IBA 06/2013 - 11/2012
2	integrin-linked kinaseIBA 10/2010 - 04/2009
2	DisulfidesIBA 01/2010 - 01/2004
2	EndotoxinsIBA 01/2010 - 01/2004
2	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 11/2006 - 01/2004
1	Biomarkers (Surrogate Marker)IBA 03/2016
1	AnthracyclinesIBA 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 06/2015
1	Ifosfamide FDA LinkGeneric 06/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2015
1	Methotrexate (Mexate)FDA LinkGeneric 06/2015
1	Ciclopirox (Loprox)FDA LinkGeneric 04/2014
1	Biological ProductsIBA 04/2014
1	U 0126 (UO 126)IBA 06/2013
1	MitogensIBA 06/2013
1	Protein Kinases (Protein Kinase)IBA 06/2013
1	Immunoconjugates (Immunoconjugate)IBA 01/2013
1	Gemtuzumab (Mylotarg)FDA Link 01/2013
1	Alemtuzumab (Campath)FDA Link 07/2012
1	IronIBA 12/2011
1	CateninsIBA 12/2011
1	HydrazonesIBA 12/2011
1	Thalidomide (Thalomid)FDA Link 01/2011
1	nasIBA 01/2011
1	Lenalidomide (CC 5013)FDA Link 01/2011
1	Bortezomib (Velcade)FDA Link 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 10/2010
1	Dasatinib (BMS 354825)FDA Link 08/2010
1	fms-Like Tyrosine Kinase 3IBA 04/2009
1	Interleukin-2 (IL2)IBA 07/2006
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2004
1	Surface Antigens (Surface Antigen)IBA 10/2004
1	Amino Acids FDA Link 01/2004
1	Immunotoxins (Immunotoxin)IBA 01/2004
1	Peptides (Polypeptides)IBA 01/2004
1	HLA-DR Antigens (HLA-DR)IBA 10/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2002

Therapy/Procedure

12	Therapeutics 01/2021 - 11/2004
7	Stem Cell Transplantation 11/2018 - 08/2005
6	Drug Therapy (Chemotherapy) 01/2018 - 01/2002
4	Transplantation 03/2016 - 06/2003
4	Hematopoietic Stem Cell Transplantation 08/2015 - 11/2005
2	Salvage Therapy 08/2015 - 04/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2004 - 01/2002
1	Consolidation Chemotherapy 11/2018
1	Heterologous Transplantation (Xenotransplantation) 03/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Cell Transplantation 06/2015
1	Induction Chemotherapy 09/2012
1	Duration of Therapy 02/2009
1	Immunotherapy 07/2006
1	Chemoradiotherapy 06/2006